These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32356572)

  • 1. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation.
    Popovics P; Jain A; Skalitzky KO; Schroeder E; Ruetten H; Cadena M; Uchtmann KS; Vezina CM; Ricke WA
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
    Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
    Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
    Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
    Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone imbalance drives macrophage infiltration and Spp1/osteopontin
    Popovics P; Skalitzky KO; Schroeder E; Jain A; Silver SV; Van Fritz F; Uchtmann KS; Vezina CM; Ricke WA
    J Pathol; 2023 Jun; 260(2):177-189. PubMed ID: 36825524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
    Wang K; Pascal LE; Li F; Chen W; Dhir R; Balasubramani GK; DeFranco DB; Yoshimura N; He D; Wang Z
    Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
    Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
    Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
    Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
    Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
    Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
    Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
    Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
    Zhao H; Ramos CF; Brooks JD; Peehl DM
    J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.
    O'Malley KJ; Eisermann K; Pascal LE; Parwani AV; Majima T; Graham L; Hrebinko K; Acquafondata M; Stewart NA; Nelson JB; Yoshimura N; Wang Z
    Prostate; 2014 Jun; 74(8):892-900. PubMed ID: 24711254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.
    Bauman TM; Vezina CM; Huang W; Marker PC; Peterson RE; Ricke WA
    Am J Clin Exp Urol; 2014; 2(4):313-22. PubMed ID: 25606577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin expression in prostate cancer and benign prostatic hyperplasia.
    Tozawa K; Yamada Y; Kawai N; Okamura T; Ueda K; Kohri K
    Urol Int; 1999; 62(3):155-8. PubMed ID: 10529666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.